dihexa human trials status 2026 clinical dihexa clinical trials Umbrella Lab Announces Documentation And Traceability Update For Dihexa Peptide Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted ADA 2026 Recap: Days 1 and 2 AngIV Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP PS1 Mouse via the PI3K AKT Signaling Pathway PMC This market will be the biggest story in healthcare in 2026, have you or anyone you know, used one of these?
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

